Allan Andersen, MD
- Risk factors for immune-related disease in individuals with substance use disorders.
Aubrey Chan, MD, PhD
- Determining the role of acid sensing channels in neuronal activity and mouse fear response.
- The outcomes and operating characteristics of integrated inpatient med-psych units.
Eric Epping, MD, PhD
- Characterization of Schizophrenia Genetic Risk Factors from Whole Exome Sequencing.
- Identification of DNA Sequence Mutations in Regions of Copy Number Variation in Schizophrenia Patients.
- Creatine Safety, Tolerability, Efficacy in Huntington's Disease
Beng Choon Ho, MD
- Adolescent Cannabis Use, Complex Brain Network Connectivity & Schizophrenia Risk.
- High-throughput Combined Assay of Multiplex Serum Biomarkers for Schizophrenia.
Karin Hoth, PhD
- Cardiopulmonary Mechanisms Affecting Cognition in COPD
Doug Langbehn, MD, PhD
- Track HD and Track-On HD
- Statistical Design of Huntington's Disease Studies and the Analysis and Modeling of HD Data.
Jeffrey Long, PhD
- Functional Connectivity in Premanifest Huntington's Disease (co-investigator)
- Network of Excellence in Neuroscience Clinical Trials (NEXT)-DCC (co-investigator)
- Basal Ganglia Shape Analysis and Circuitry in Huntington's Disease (PREDICT-HD) (co-investigator)
- Neurobiological Predictors of Huntington's Disease (PREDICT-HD) (co-investigator)
Alison Lynch, MD, MS
- Medication for Addiction Treatment (MAT) for Opioid Use Disorder
- Service Delivery and Treatment for Substance Use Disorders
- Neuromodulation with Transcranial Magnetic Stimulation in the Treatment of Methamphetamine Use Disorder
- Emotional Experiences of Polycystic Ovary Syndrome
Jacob Michaelson, PhD
- Genetics of neurodevelopmental conditions (ASD, ID, DD)
- Gender differences in neurodevelopmental conditions
- Genetics of language ability
- Machine learning to improve the interpretation of non-coding genetic variants
- Functional and regulatory genomics in the brain
Del Miller, MD, PharmD
- ACLAIMS (A Comparison of Long-Acting Injectable Medications for Schizophrenia)
- Phase III Study of an Adjunctive Medication for Patients with Schizophrenia with Persistent, Predominant Negative Symptoms
- Phase III Study of an Adjunctive Medication for Patients with Schizophrenia with Sub-Optimally Controlled Symptoms
David Moser, PhD
- Vascular Function, Cognition, and Brain MRI in Atherosclerotic Vascular Disease
Mark Niciu, MD, PhD
- Experimental Therapeutics of Major Mood Disorders
- Co-occurring Psychiatric and Substance Use Disorders
Krystal Parker, PhD
- Cerebellar contribution to cognition
- Potential for cerebellar stimulation to rescue cognitive impairments in humans with schizophrenia
Robert Philibert, MD, PhD
- The Effects of Smoking on DNA Methylation in Primary Human Lymphocyte
- Examination of Genetic and GxE Effects in the Family and Community Health Studies
- Factors Influencing the Health Behaviors if Young African American Adults
- Using DNA Methylation to Determine Recent Alcohol Consumption Patterns
- A Transdisciplinary Center Focused on Rural African American Families
Anthony Purgianto, MD, PhD
- Interventional Psychiatry/Neuromodulation (ECT, TMS, Ketamine, DBS, VNS treatments) for mood disorders
- Neuromodulation Task Force Consensus Recommendations for TMS in Depression
- National Network of Depression Centers
Jordan Schultz, PharmD
- AUTO-HD: Autonomic Function in Huntington's Disease Study
- TZ-PD: Terazosin for Parkinson's Disease Study
- TZ-HD: Terazosin for Huntington's Disease Study
- TZ-AD: Terazosin for Alzheimer's Disease Study
- WEAR-HD: Wearable Device in Huntington's Disease Study
Susan Shen, MD, PhD
- Bridging the gap between basic science and health services research by studying the interface of nature and nurture
- Improving the detection and treatment of neuropsychiatric disorders by identifying cellular endophenotypes and their molecular correlates, in the context of genetic and environmental factors
Hanna E. Stevens, MD, PhD
- Pesticide exposure during neurodevelopment
- The Influence of Placental IGF-1 Expression on Fetal Striatal Development
- Effects of Prenatal Stress on the Striatum
Nick Trapp, MD, MS
- University of Iowa Interventional Psychiatry Service Patient Registry
- Cerebellar Stimulation and Cognitive Control
- DBS for OCD
- TMS Targeting
- Transcranial Magnetic Stimulation Pilot Study for Methamphetamine Use Disorder
Beth Troutman, PhD
- Parent-Child Interaction Therapy
Carolyn Turvey, PhD
- Combined Illness Management and Psychotherapy in Treating Depressed Elders
- MyHealtheVet Project: Blue Button Feature Evaluation
- DRI Training: the Conduct of Psychosocial Care Interventional
Tom Wassink, MD
- A Family-Genetic Study of Language in Autism
Andrea Weber, MD, MME
- Training Expansion in Addiction Medicine and Medications for Addiction Treatment at the University of Iowa (TEAM-MAT-UI)
John Wemmie, MD, PhD
- Brain pH and Acid Sensing in Depression Related Behavior
- Modeling CO2-Evoked Fear in Mice: Role of Acid-Sensing Ion Channels
- Regulation of Cerebral Blood Flow by Acid-Sensing Ion Channels (ASICs)
- Anti-depressant Effects of Targeting ASIC1a in the Nucleus Accumbens
Aislinn Williams, MD, PhD
- Developmental pathways involved in neuropsychiatric disease
- Voltage-gated calcium channel genes
Virginia Willour, PhD
- Attempted Suicide Candidate Gene Resequencing
- Suicide Epigenetics
- Genetic Risk Factor for Suicidal Behavior